|Bid||6.20 x 0|
|Ask||6.21 x 0|
|Day's Range||6.08 - 6.50|
|52 Week Range||4.76 - 18.63|
|Beta (3Y Monthly)||3.53|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
The vaping crisis has brought on some twists and turns for the cannabis sector. New York courts are now weighing an e-cigarette ban.
Despite vaping concerns, Aurora Cannabis plans to introduce vape products in December. Reports of vaping-related illnesses started in late August.
Cronos Group (CRON) stock rose 33% with a heavy volume in after-hours trading on Wednesday. Marijuana stocks are on a rollercoaster ride.
On Wednesday, Aurora Cannabis gave a preview of its Cannabis 2.0 strategy. The company provided plans for the roll-out of edibles, concentrates, and vapes.
It’s been a year since cannabis went legal, and Aphria Inc. (TSX:APHA)(NYSE:APHA) is rocketing 25% after positive first-quarter results.
In 2007, New Mexico was the 12th state to legalize medical cannabis in the US. However, the state hasn't legalized marijuana for recreational use.
Aphria (APHA) reported impressive results for the first quarter of fiscal 2020 on Tuesday. The stock has gained 9.6% since its earnings.
TORONTO — Some of the most active companies traded Wednesday on the Toronto Stock Exchange:Toronto Stock Exchange (16,427.18, up 8.79 points).Aphria Inc. (TSX:APHA). Health care. Down 76 cents, or 10.6 per cent, to $6.41 on 5.9 million shares.Aurora Cannabis Inc. (TSX:ACB). Health care. Down 23 cents, 4.63 per cent, to $4.74 on 5.2 million shares.Manulife Financial Corp. (TSX:MFC). Financials. Up 11 cents, or 0.46 per cent, to $24.28 on five million shares.Encana Corp. (TSX:ECA). Energy. Down three cents, or 0.53 per cent, to $5.63 on 4.9 million shares.CannTrust Holdings Inc. (TSX:TRST). Health care. Down seven cents, or 3.85 per cent, to $1.75 on 4.2 million shares.B2Gold Corp. (TSX:BTO). Materials. Up four cents, or 0.95 per cent, to $4.23 on 4 million shares. Companies in the news:Air Canada (TSX:AC). Down 25 cents to $45.38. Several Canadian airlines have scrubbed the phrase "ladies and gentlemen" from their in-flight announcements — or are considering the change — replacing the gendered language with non-binary terminology as part of a broader shift toward corporate inclusivity. Air Transat said in an email it has stopped using the salutation as well as its French equivalent, "Mesdames et messieurs." Air Canada says it will do likewise, amending its on-board announcements "to modernize them and remove specific references to gender." Porter Airlines jettisoned "ladies and gentlemen" in 2018. WestJet Airlines Ltd. and Sunwing Airlines Inc. still include the time-worn phrase in their in-flight announcements, but say they are mulling an edit.Loblaw Companies Ltd. (TSX:L). Down 98 cents to $71.62. Canada's privacy commissioner says Loblaw Companies Ltd. initially collected too much personal information from some customers requesting a gift card tied to an alleged bread price-fixing scandal. The Office of the Privacy Commissioner of Canada says its investigation found Loblaw failed to explain to people that sensitive information like driver's licence numbers, birthdays and digital photos could be redacted, while a name and address were needed to verify an identity. Loblaw offered the $25 gift card as a goodwill gesture after admitting it participated in an alleged industry-wide arrangement to co-ordinate bread price increases.SIR Royalty Income Fund. (TSX:SRV.UN). Down $2.89, or 21 per cent, to $10.87. SIR Royalty Income Fund units fell to a multi-year low Wednesday after it warned that investor payouts will drop 16.7 per cent to reflect a drop in food and drink sales at its restaurants, which include the Jack Astors chain. SIR said same-store sales for its operating company's fourth quarter, which ended Aug. 25, were down 5.9 per cent and didn't improve during the first four weeks of its 2020 financial year. As a result, the trust will lower the monthly cash distributions to be paid on SIR Royalty units by 1.75 cents to 8.75 cents per unit, starting in November, down from 10.5 cents per unit.Hexo Corp. (TSX:HEXO). Down 12 cents or 3.56 per cent to $3.25. Cannabis company Hexo Corp. is moving to undercut prices in the illicit market with a new 28-gram product that costs consumers as much as one dollar less per gram than at the average illegal dispensary. The product, under the brand Original Stash, which will be on sale in Quebec cannabis stores starting Thursday for $125.70, or $4.49 per gram, including taxes, the company said. That's cheaper than the average cost of a gram of cannabis at $7.37 per gram during the third quarter, with the price of legal and illegal weed at $10.23 and $5.59 per gram, respectively, according to the latest Statistics Canada analysis of crowdsourced data. This report by The Canadian Press was first published Oct. 16, 2019.The Canadian Press
Hexo launched Original Stash, a value cannabis brand. Hexo's CEO stated that the company intends to educate consumers and "disrupt the illicit market."
Aphria Inc. (TSX:APHA ) (NYSE:APHA) first quarter results include non-operating income which resulted in a low quality net profit, but longer term, the company is on the right path.
Two Pennsylvania senators introduced a comprehensive marijuana legalization bill on Tuesday. Senator Daylin Leach and Sharif Street introduced the bill.
Aphria Inc (TSX:APHA)(NYSE:APHA) reported earnings Tuesday morning that was well received by the market, but what does it say about the industry as a whole?
Brexit News Changing By the Hour As Clock Ticks Down, Again Brexit deal, or no Brexit deal, that is the question. Nobody knows the answer, but the news stories just keep coming, with every new one contradicting the last. The latest is that there is no deal, as assessments from unspecified political experts are “gloomy”. […]The post Market Morning: Brexit Back'n'Forth, Carrie Lam Booed Off Stage, Buffett Wants BofA, Balkman Blunders appeared first on Market Exclusive.
Shares of Aphria Inc. jumped by as much as 18 per cent as the cannabis company reported a profit of $16.4 million in its latest quarter — its second consecutive quarter of profitable growth.The Leamington, Ont.-based pot producer's stock closed at $7.17 on Tuesday afternoon on the Toronto Stock Exchange, up roughly 15.5 per cent, after reaching as high as $7.33 earlier in the day.Its interim chief executive Irwin D. Simon said during the quarter ended Aug. 31, the pot company was able to increase its market share to 12 per cent, based on data from the Ontario Cannabis Store."Aphria brands continue to gain momentum in the Canadian marketplace... We were able to gain a significant amount of share during the quarter from our competitors, driven by brand awareness, nationwide distribution and the quality of our products," he told analysts on a conference call. The company said the profit amounted to seven cents per share, up from $15.8 million or five cents per share in the prior quarter and net income of $21.2 million or nine cents per share for the same period last year.Aphria's latest earnings beat the two cent per share loss expected by analysts, according to the financial markets data firm Refinitiv.Revenue for what was the first quarter of the company's 2020 financial year totalled $126.1 million, down slightly from $128.6 million in the prior quarter but up more than 800 per cent from $13.3 million a year ago before legalization of recreational cannabis in Canada.In its outlook, Aphria reaffirmed its guidance for net revenue of about $650 million to $700 million in its 2020 financial year, with distribution revenue representing slightly more than half of the total net revenue.Its adjusted earnings before interest, taxes, depreciation and amortization for the year are expected to be approximately $88 million to $95 million, it added."We believe our financial results truly set us apart from our peers in the adult-use cannabis industry," Simon told analysts.Aphria's surprise profit and positive forward guidance comes after two of its peers recently cut or missed their own earnings forecasts, which they attributed to various factors such as a slower than expected retail rollout and delays in government approvals for new cannabis derivative products, such as edibles.Last week, Gatineau, Que.-based Hexo Corp. cut its net revenue forecast for the quarter ended July 31 from $26 million to between $14.5 million to $16.5 million, "primarily due to lower than expected product sell through."And last month, Edmonton-based Aurora Cannabis reported net revenues of $98.9 million for its quarter ended June 30, marking an increase from the prior year but lower than the range of between $100 million and $107 million it predicted earlier, pointing to the slow rollout of stores in Ontario.Aphria, however, said during its latest quarter that its adult-use cannabis revenues amounted to $20 million, up eight per cent from the prior quarter. "Given the recent broader sector correction and indications of industry transition pain, we view Aphria's Q1 results as solid," said Justin Keywood, an analyst with GMP Securities in a note to clients.Aphria's confirmation of sales should be seen as a "big positive" amid concerns around wider industry pressures and a wave of recent street downgrades, said Owen Bennett, an analyst with Jefferies."We have argued these downgrades have not reflected worsening industry conditions but are simply a function of the street being too high in the first place... Where we have seen certain companies pull back on guidance such as Hexo, we think this reflects soft consumer traction for their brands, as opposed to industry weakness," Bennett wrote in a note to clients.Aphria's second-consecutive quarterly profit comes nearly one year after Canada legalized recreational pot and after a tumultuous period for the company.The pot producer has been without a permanent chief executive since Vic Neufeld retired on March 1, a departure that came after Aphria faced allegations in December by short-sellers that argued its acquisitions in Latin America were purchased at vastly inflated prices to benefit insiders. Aphria denied the allegations, and a board committee later reviewed the deals and deemed that they were within an acceptable range.Also, earlier this month cannabis company Aleafia Health Inc. terminated its wholesale pot supply agreement with Aphria for up to 175,000 kilogram equivalents of products over five years, citing its "failure to meet its supply obligations." Aphria said that it had every intention of fulfilling its obligations, and it made "good faith" efforts to ensure continuation of the agreement but the deal was not a material part of its operations.Aphria executives told analysts on Tuesday that it expects to replace the Aleafia deal with retail customers and other products. This report by The Canadian Press was first published Oct. 15, 2019.Companies in this story: (TSX:APHA)Armina Ligaya, The Canadian Press
With a boost from Aphria’s (APHA) impressive first-quarter earnings, cannabis stocks and ETFs were trading higher today. Let's take a closer look.
Aphria (TSX:APHA)(NYSE:APHA) stock jumped nicely by about 20% this morning after reporting its second profitable earnings this morning.
(Bloomberg) -- Aphria Inc. became the first large pot producer to report a second consecutive profitable quarter Tuesday, sending its stock up as much as 18%.The company said it earned C$16.4 million on revenue of C$126.1 million in the quarter ended Aug. 31, a slight decline from the prior period. It also reiterated its outlook for fiscal 2020, which calls for revenue of C$650 million to C$700 million and adjusted Ebitda of C$88 million to C$95 million.Notably, revenue from recreational cannabis sales rose 8% quarter-over-quarter to C$20 million. The increase comes as other companies like Canopy Growth Corp. and Aurora Cannabis Inc. have reported sales declines or warned of an impending slowdown. Hexo Corp. withdrew its guidance for fiscal 2020 last week, citing slower-than-expected store openings, a delay in government approval for new products and early signs of pricing pressure. Other companies are still having trouble supplying the market.Aphria’s interim Chief Executive Officer Irwin Simon said he hasn’t seen a slowdown in sales or pricing pressure.“I always thought there was something out there called supply and demand,” Simon said in a phone interview. “If there’s still supply issues, I’m not sure how the pricing pressure is being applied against companies that are having issues supplying.”Aphria also took market share from its competitors in the quarter. In Ontario, Canada’s most populous province, it gained four points to 12% of the market, Simon said.Aphria’s stock increase was the largest since its last quarterly report on Aug. 2. Prior to Tuesday, the stock had lost about 16% since the beginning of the month amid broader weakness in the pot sector.“We believe the reaction is due to industry sentiment (and valuations) near all-time lows, making an in-line quarter very well received by many industry investors,” CIBC analyst John Zamparo said in a note.Other cannabis producers also joined in the gains, with the ETFMG Alternative Harvest ETF adding 6.9%. Tilray Inc. rose 8.9%, Cronos Group Inc. gained 7.8% and Organigram Holdings Inc. jumped 16%.Aphria has posted a remarkable turnaround since late last year, when it was the target of short sellers who accused it of paying inflated prices to buy Latin American assets from insiders. That resulted in the ousting of Chief Executive Officer Vic Neufeld, who was replaced on an interim basis by Simon, former CEO of Hain Celestial Group Inc.Simon said in August that he was “absolutely” interested in acquiring assets from CannTrust Holdings Inc., which had its license suspended following a regulatory breach. He was less definitive on Tuesday.“There’s a big focus today at Aphria on our medical cannabis business, and if I don’t have to go buy assets and those patients are there and I can build it on my own, that’s a better place to be,” he said.(Updates with CEO comments from interview.)To contact the reporter on this story: Kristine Owram in Toronto at firstname.lastname@example.orgTo contact the editors responsible for this story: Brad Olesen at email@example.com, Will Daley, Richard RichtmyerFor more articles like this, please visit us at bloomberg.com©2019 Bloomberg L.P.